ArticleScientific reports2026
Using machine learning algorithms to predict MACE in peritoneal dialysis patients.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The study aimed to predict the risks of Major adverse cardiac events (MACE) in patients undergoing peritoneal dialysis (PD) with machine learning (ML) algorithm. In addition, we added the time factor and predicted the risk factors for MACE during the 1-year and 5-year follow-up. This retrospective study included 1006 PD patients from January 2010 to December 2016. XGBoost, Random Forest (RF) and Adaboost were used to train models for assessing risk of 1-year and 5-year MACE. The optimal ML algorithm was used to construct the models to predict the risk of the MACE end point. 409 patients developed MACE during the follow-up. The RF model (AUC = 0.80) was optimal for overall MACE prediction. The three most influential variables, ranked in descending order of importance were Parathyroid hormone, Congestive heart failure and Age.114 patients developed MACE during the first-year follow-up. The XGBoost model (AUC = 0.86) performed best for 1-year MACE. The three most influential variables, ranked in descending order of importance were High-Density Lipoprotein Cholesterol (HDL-C), Age and Calcium. 331 patients developed MACE during the 5-year follow-up. The RF model (AUC = 0.75) was the best predicting model for 5-year MACE. The three most influential variables, ranked in descending order of importance were Age, Creatinine and estimated Glomerular Filtration Rate. We developed and validated a novel algorithm to predict the risk factors of MACE in PD patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.